The Market

The transcatheter mitral valve replacement market is facing substantial growth in the near future [1], estimated at 15B USD.

Leaf shape vector art
Leaf shape vector art
Leaf shape vector art
Payment vector art

2%

MR patients referred to surgery

This is the percentage of MR patients referred to Mitral Valve surgery, annually. The remaining 98% are deemed inoperable due to high-risk of surgical morbidity, and are left without an optimal solution [3].

4M

MR Patients in he US

More than 4 million people in the U.S. suffer from mitral regurgitation, with around 50,000 new cases annually [1].

15B

MVR Market Estimate

Due to rise in incidences of valvular heart diseases worldwide, along with increasing demand for less invasive procedures is propelling the industry growth. Growing geriatric population suffering from heart valve diseases is leading to increase in valve replacement surgeries [2].